2BB score and signals
Kalaris Therapeutics, Inc.’s current 2BB score is 29 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 11 | Very Low |
| Momentum | 16 | Strongly Weakening |
| Financial strength | 0 | Very Weak |
| Quality | 40 | Normal |
| Risk | 45 | Moderate |
Company facts
| Headquarters | Berkeley Heights, New Jersey, United States |
| Founded | 2019 |
| Employees | 20 |
| 52-week range | $2.14 – $11.88 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.5188 | — | $0.00 |
| 2026-08-19 | — | -0.5049 | — | $0.00 |
| 2026-05-12 | -0.46 | -0.5336 | $0.00 | $0.00 |
| 2026-03-17 | -0.51 | -0.5421 | — | $0.00 |
Related companies
2BBBullish & Bearish